Affiliation
Research projects
Active research projects
Personalized treatment – TDM and pharmacogenetics
This project is an assessment of variation in exposure and response to psychoactive drugs.
Publications and research
Scientific publications (34)
- Hole, Kristine; Lorentsen, Silje K.; Nordby, Karoline L; Slettvik, Marie; Sørum, Ida T. G.; Molden, Espen; Haslemo, Tore (2024). Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets. European Journal of Clinical Pharmacology
- Faraj, Pari; Haslemo, Tore; Tran, Jenny Phung; Stingl, Julia; Molden, Espen; Hole, Kristine (2024). Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population. British Journal of Clinical Pharmacology
- Hole, Kristine; Gangsø, Sofie; Jensstuen, Åse Tonette; Ormøy, Hanne Holte; Paulsen, Maren; Molden, Espen; Haslemo, Tore (2023). Effect of CYP2D6 genotype on duloxetine serum concentration. Basic & Clinical Pharmacology & Toxicology. Vol. 134. p. 186-192
- Hole, Kristine; Haslemo, Tore; Molden, Espen (2023). Impact of CYP2D6 Genotype on Paroxetine Serum Concentration. Therapeutic Drug Monitoring. Vol. 45. p. 683-688
- Solhaug, Vigdis; Haslemo, Tore; Kringen, Marianne Kristiansen; Molden, Espen; Dietrichs, Erik Sveberg (2022). Genotyping av pasienter behandlet med selektive serotoninreopptakshemmere. Tidsskrift for Den norske legeforening (Tidsskriftet). Vol. 142. p. 1-10
- Dietrichs, Erik Sveberg; Solhaug, Vigdis; Haslemo, Tore; Kringen, Marianne K.; Molden, Espen (2022). E.S. Dietrichs og medarbeidere svarer. Tidsskrift for Den norske legeforening (Tidsskriftet). Vol. 142
- Bråten, Line Skute; Haslemo, Tore; Jukić, Marin M.; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K. (2021). A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram. Clinical Pharmacology and Therapeutics. Vol. 110. p. 786-793
- Tveito, Marit; Høiseth, Gudrun; Haslemo, Tore; Molden, Espen; Smith, Robert Løvsletten (2021). Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients. European Journal of Clinical Pharmacology. Vol. 77. p. 1201-1208
- Hole, Kristine; Arnestad, Marianne; Molden, Espen; Haslemo, Tore (2021). Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients with Depression. Journal of Clinical Psychopharmacology. Vol. 41. p. 281-285
- Kringen, Marianne K.; Bråten, Line Skute; Haslemo, Tore; Molden, Espen (2020). The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O -Desmethylvenlafaxine Concentrations in a Large Patient Cohort. Journal of Clinical Psychopharmacology. Vol. 40. p. 137-144
- Bråten, Line Skute; Haslemo, Tore; Jukic, Marin M.; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K. (2019). Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients. Neuropsychopharmacology. Vol. 45. p. 570-576
- Smith, Robert Løvsletten; Kyllesø, Lennart; Haslemo, Tore; Andreassen, Ole Andreas; Molden, Espen (2019). Reduction in N-desmethylclozapine level is determined by daily dose but not serum concentration of valproic acid-indications of a presystemic interaction mechanism. Therapeutic Drug Monitoring. Vol. 41. p. 503-508
- Gjestad, Caroline; Hole, Kristine; Haslemo, Tore; Diczfalusy, Ulf; Molden, Espen (2019). Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol—an Interaction Study in Healthy Volunteers. AAPS Journal. Vol. 21
- Jukic, Marin M.; Smith, Robert Løvsletten; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus (2019). Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study. The Lancet Psychiatry. Vol. 6. p. 418-426
- Haslemo, Tore; Eliasson, Erik; Jukic, Marin M.; Ingelman-Sundberg, Magnus; Molden, Espen (2018). Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients. British Journal of Clinical Pharmacology
- Tveito, Marit; Smith, Robert Løvsletten; Molden, Espen; Haslemo, Tore; Refsum, Helge; Hartberg, Cecilie Bhandari; Correll, Christoph U.; Høiseth, Gudrun (2018). Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations: An Observational Study Including 8,288 Patients. Journal of Clinical Psychopharmacology. Vol. 38. p. 570-576
- Smith, Robert Løvsletten; Haslemo, Tore; Chan, Hilde Fauskrud; Refsum, Helge; Molden, Espen (2018). Clinically Relevant Effect of UGT1A4*3 on Lamotrigine Serum Concentration Is Restricted to Postmenopausal Women—A Study Matching Therapeutic Drug Monitoring and Genotype Data From 534 Patients. Therapeutic Drug Monitoring. Vol. 40. p. 567-571
- Hole, Kristine; Wollmann, Birgit Malene Tovik; Nguyen, Camilla; Haslemo, Tore; Molden, Espen (2018). Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker. Therapeutic Drug Monitoring. Vol. 40. p. 463-468
- Jukic, Marin M.; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus (2018). Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients. American Journal of Psychiatry. Vol. 175. p. 463-470
- Gjestad, Caroline; Haslemo, Tore; Andreassen, Ole Andreas; Molden, Espen (2017). 4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients. British Journal of Clinical Pharmacology. Vol. 83. p. 2398-2405
- Hole, Kristine; Størset, Elisabet; Olastuen, Ane; Haslemo, Tore; Kro, Grete Birkeland; Midtvedt, Karsten; Åsberg, Anders; Molden, Espen (2017). Recovery of CYP3A Phenotype after Kidney Transplantation. Drug Metabolism And Disposition. Vol. 45. p. 1260-1265
- Hole, Kristine; Gjestad, Caroline; Heitmann, Kristine; Haslemo, Tore; Molden, Espen; Bremer, Sara (2017). Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol concentration. European Journal of Clinical Pharmacology. Vol. 73. p. 317-324
- Smith, Robert Løvsletten; Haslemo, Tore; Andreassen, Ole Andreas; Eliasson, Erik; Dahl, Marja-Liisa; Spigset, Olav; Molden, Espen (2017). Correlation between serum concentrations of N-desmethylclozapine and granulocyte levels in patients with schizophrenia: a retrospective observational study. CNS Drugs. Vol. 31. p. 991-997
- Parker, Krystina; Aasebø, Willy; Haslemo, Tore; Stavem, Knut (2016). Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients. SpringerPlus. Vol. 5
- Smith, Robert Løvsletten; Haslemo, Tore; Refsum, Helge; Molden, Espen (2016). Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid—a large-scale study based on naturalistic therapeutic drug monitoring data. European Journal of Clinical Pharmacology. Vol. 72. p. 1099-1104
- Mannheimer, Buster; Haslemo, Tore; Lindh, Jonatan D.; Eliasson, Erik; Molden, Espen (2016). Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype. Therapeutic Drug Monitoring. Vol. 38. p. 127-134
- Gjestad, Caroline; Huynh, Duy Khanh; Haslemo, Tore; Molden, Espen (2016). 4β-Hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?. British Journal of Clinical Pharmacology. Vol. 81. p. 269-276
- Molden, Espen; Waade, Ragnhild Birkeland; Hoff, Maren; Haslemo, Tore (2016). Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype. Basic & Clinical Pharmacology & Toxicology. Vol. 119. p. 470-475
- Høiseth, Gudrun; Haslemo, Tore; Uthus, Linda Hårstad; Molden, Espen (2015). Effect of CYP2B6*6 on steady-state serum concentrations of bupropion and hydroxybupropion in psychiatric patients: A study based on therapeutic drug monitoring data. Therapeutic Drug Monitoring. Vol. 37. p. 589-593
- Söderberg, Mao Mao; Haslemo, Tore; Molden, Espen; Dahl, Marja-Liisa (2013). Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients. The Pharmacogenomics Journal. Vol. 13. p. 544-550
- Söderberg, Mao M.; Haslemo, Tore; Molden, Espen; Dahl, Marja-Liisa (2013). Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure. Pharmacogenetics & Genomics. Vol. 23. p. 279-285
- Haslemo, Tore; Loryan, I; Ueda, N; Mannheimer, B; Bertilsson, L; Ingelman-Sundberg, M; Molden, Espen; Eliasson, E (2012). UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems. Clinical Pharmacology and Therapeutics. Vol. 92. p. 221-227
- Haslemo, Tore; Olsen, Kristine Marie; Lunde, Hilde; Molden, Espen (2012). Valproic Acid Significantly Lowers Serum Concentrations of Olanzapine-An Interaction Effect Comparable With Smoking. Therapeutic Drug Monitoring. Vol. 34. p. 512-517
- Haslemo, Tore; Refsum, Helge; Molden, Espen (2011). The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine. British Journal of Clinical Pharmacology. Vol. 71. p. 611-615
Research reports (1)
- Haslemo, Tore; Refsum, Helge; Molden, Espen (2012). Pharmacokinetic Variability of Olanzapine : A Study Based on Therapeutic Drug Monitoring Data. Universitetet i Oslo
Dissemination (7)
- Dietrichs, Erik Sveberg; Solhaug, Vigdis; Kringen, Marianne Kristiansen; Haslemo, Tore; Molden, Espen (2022). E. S. Dietrichs og medarbeidere svarer P. Gjerden. Tidsskrift for Den norske legeforening (Tidsskriftet)
- Dietrichs, Erik Sveberg; Haslemo, Tore; Kringen, Marianne K.; Molden, Espen; Solhaug, Vigdis (2022). E. S. Dietrichs og medarbeidere svarer. Tidsskrift for Den norske legeforening (Tidsskriftet). Vol. 142
- Dietrichs, Erik Sveberg; Molden, Espen; Haslemo, Tore (2022). Senter for psykofarmakologi. LVS-info
- Landmark, Cecilie Johannessen; Baftiu, Arton; Haslemo, Tore (2018). Identification and handing of pharmacokinetic interactions of antiepileptic- and psychoactive drugs. 18th international congress of IATDMCT
- Gjestad, Caroline; Haslemo, Tore; Andreassen, Ole Andreas; Molden, Espen (2018). Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker. British Journal of Clinical Pharmacology. Vol. 84. p. 1624-1625
- Haslemo, Tore; Baftiu, Arton; Gottås, André; Burns, Margrete Larsen; Landmark, Cecilie Johannessen (2017). Pharmacokinetic drug interactions with valproate and antiepileptic or antipsychotic drugs – still a mystery after 50 years?. 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology,
- Solberg, Dag Kristen; Haslemo, Tore; Refsum, Helge (2012). Psykofarmakologisk poliklinikk. Tidsskrift for Den norske legeforening (Tidsskriftet). Vol. 132. p. 1065-1067
These publications are obtained from Norwegian Research Information Repository. The list may be incomplete.
